News

CHEST News

Safeguarding Evidence-Based Vaccine Policy: June 12, 2025
The Respiratory Impact of Federal Funding Cuts: May 2, 2025
An Update on Supplemental Oxygen Bill in Congress: April 18, 2025; See all >

Nerandomilast opens the door for potential monotherapy, add-on therapy for pulmonary fibrosis: September 17, 2025 - Positive results from the FIBRONEER trials of nerandomilast in IPF and PPF have sent the phosphodiesterase 4B inhibitor to the FDA for marketing approval. If approved, nerandomilast would be the first new antifibrotic agent for ILD in more than a decade.
Prevention of COPD exacerbations with an eosinophilic endotype: September 17, 2025 - With the recent US approval of the IL-5-directed monoclonal antibody mepolizumab as an add-on therapy for patients with COPD, the era of COPD biologics is undeniably here.
Moderate to severe OSA increases risk of severe COVID-19: September 17, 2025 - According to critical care specialist Lina Miyakawa, MD, FCCP, the findings are a reminder that OSA “is not just a sleep disorder but a systemic condition with meaningful public health implications.”; See all >

Inspirational cancer survivor, adventurer to deliver CHEST 2025 keynote address: September 10, 2025 - During the CHEST 2025 Opening Session, Sean Swarner will share lessons learned from his battle with two terminal cancers during childhood and his journey to become the first cancer survivor to crest the summit of Mount Everest—with just one functioning lung, no less.
Explore recent developments in the treatment of sleep disorders: September 10, 2025 - Multiple sessions will focus extensively on the benefits of glucagon-like peptide-1 (GLP-1) agonists in sleep medicine, said Chitra Lal, MD, MBBS, FCCP, Chair of the Sleep Medicine Curriculum Group and Sleep Medicine Network.
Add to your expertise with advanced sessions at CHEST 2025: September 10, 2025 - More than 100 sessions will cater specifically to clinicians with substantial experience and deep content knowledge, said Sandhya Khurana, MD, FCCP, CHEST 2025 Scientific Program Committee Chair.; See all >

Approaching Multidrug-Resistant TB With Shorter and Better Tolerated Oral Drug Regimens: May 21, 2025
Mentoring an LGBTQ+ Mentee: May 14, 2025
Thank You, Volunteers: April 18, 2025; See all >

How to Start Your Leadership Journey With CHEST: May 31, 2024
My Path for Board Recertification: June 28, 2023
Slow Is Smooth and Smooth Is Fast: My Journey in Preparing for My Pulmonary Board Certification: June 28, 2023; See all >